KNUST HENNER has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CEREP SA, REDDY RESEARCH FOUNDATION and EXELIXIS PATENT CO LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Knust Henner | 17 |
#2 | Nettekoven Matthias | 16 |
#3 | Ratni Hasane | 10 |
#4 | Vifian Walter | 9 |
#5 | Riemer Claus | 7 |
#6 | Roche Olivier | 6 |
#7 | Pinard Emmanuel | 6 |
#8 | Rogers-Evans Mark | 6 |
#9 | Limberg Anja | 3 |
#10 | Koblet Andreas | 3 |
Publication | Filing date | Title |
---|---|---|
US2012178761A1 | Pyrrolidine derivatives | |
US2011152233A1 | Pyrrolidine compounds | |
US2011144081A1 | Pyrrolidine derivatives | |
US2010256126A1 | Piperidine derivatives as NK3 receptor antagonists | |
US2010210659A1 | Pyrrolidine derivatives as NK3 receptor antagonists |